PMID- 25769588 OWN - NLM STAT- MEDLINE DCOM- 20150917 LR - 20181202 IS - 1873-2623 (Electronic) IS - 0041-1345 (Linking) VI - 47 IP - 2 DP - 2015 Mar TI - Prevalence of hypertension after living-donor liver transplantation: a prospective study. PG - 445-50 LID - S0041-1345(14)01241-X [pii] LID - 10.1016/j.transproceed.2014.10.050 [doi] AB - BACKGROUND: Hypertension is common among patients who have undergone liver transplantation and is a major contributor to cardiovascular events. Few studies have studied the risk factors associated with post-liver transplantation (LT) hypertension. This prospective study assessed the prevalence of post-LT hypertension and associated preoperative risk factors. METHODS: From May 2008 to December 2009, 79 normotensive adult patients (>/= 18 years old) who underwent living-donor LT with a median follow up of 4.79 +/- 0.88 years were enrolled. Patients' pre-LT demographics, clinical data, pre-LT diabetes, and immunosuppressive agents used after LT were studied for their association with post-LT hypertension. RESULTS: The prevalence of post-LT hypertension was 49.4%. The independent risk factors for post-living-donor LT hypertension were pre-LT systolic blood pressure (SBP; odds ratio [OR], 1.04; 95% confidence interval [CI], 1.00-1.09; P = .039) and post-LT administration of mammalian target of rapamycin (mTOR) inhibitors (OR, 4.08; 95% CI, 1.40-11.94; P = .010). Pre-LT diabetes had a negative predictive value (OR, 0.15; 95% CI, 0.03-0.74; P = .019). Neither age, male sex, smoking, pre-LT serum cholesterol and triglyceride levels, tacrolimus, nor glucocorticoid was associated with post-LT hypertension. CONCLUSIONS: The prevalence of hypertension is high after LT. Higher pre-LT SBP and post-LT mTOR inhibitor administration predispose patients to post-LT hypertension. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Tong, M-S AU - Tong MS AD - Section of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China; Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China. FAU - Chai, H-T AU - Chai HT AD - Section of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China; Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China. FAU - Liu, W-H AU - Liu WH AD - Section of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China; Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China. FAU - Chen, C-L AU - Chen CL AD - Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China; Liver Transplantation Program, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China. FAU - Fu, M AU - Fu M AD - Section of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China; Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China. FAU - Lin, Y-H AU - Lin YH AD - Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China; Liver Transplantation Program, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China. FAU - Lin, C-C AU - Lin CC AD - Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China; Liver Transplantation Program, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China. FAU - Chen, S-M AU - Chen SM AD - Section of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China. Electronic address: syming99@gmail.com. FAU - Hang, C-L AU - Hang CL AD - Section of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Republic of China; Chang Gung University College of Medicine, Kaohsiung City, Taiwan, Republic of China. LA - eng PT - Clinical Trial PT - Journal Article PL - United States TA - Transplant Proc JT - Transplantation proceedings JID - 0243532 SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Female MH - Follow-Up Studies MH - Humans MH - Hypertension/epidemiology/*etiology MH - Liver Transplantation/*methods MH - *Living Donors MH - Logistic Models MH - Male MH - Middle Aged MH - Odds Ratio MH - *Postoperative Complications/epidemiology MH - Preoperative Period MH - Prevalence MH - Prospective Studies MH - Risk Factors MH - Young Adult EDAT- 2015/03/15 06:00 MHDA- 2015/09/18 06:00 CRDT- 2015/03/15 06:00 PHST- 2014/07/30 00:00 [received] PHST- 2014/10/10 00:00 [revised] PHST- 2014/10/28 00:00 [accepted] PHST- 2015/03/15 06:00 [entrez] PHST- 2015/03/15 06:00 [pubmed] PHST- 2015/09/18 06:00 [medline] AID - S0041-1345(14)01241-X [pii] AID - 10.1016/j.transproceed.2014.10.050 [doi] PST - ppublish SO - Transplant Proc. 2015 Mar;47(2):445-50. doi: 10.1016/j.transproceed.2014.10.050.